JVCZY yields 0.37% · PFE yields 6.13%● Live data
📍 JVCZY pulled ahead of the other in Year 1
Combined, JVCZY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JVCZY + PFE for your $10,000?
JVCKENWOOD Corporation manufactures and sells products in the mobility and telematics services, public service, and media service sectors in Japan and internationally. The Mobility & Telematics Services Sector segment manufactures and sells car AV systems, car navigation systems, car audio systems, dashcams, in-vehicle devices, etc., as well as telematics solutions. The Public Service Sector segment manufactures and sells professional wireless communications devices, video surveillance and audio equipment, medical image display systems, etc. The Media Service Sector segment offers professional video cameras, projectors, headphones, commercial video cameras, home audio equipment, portable power supplies, etc.; CDs and DVDs (packaged software), etc.; and audio and video software, content distribution, etc. The Others segment provides service parts, etc. The company also provides contract manufacturing service of electronic devices. The company sells its products under the JVC, Victor, and KENWOOD brands. The company was formerly known as JVC KENWOOD Holdings, Inc. and changed its name to JVCKENWOOD Corporation in August 2011. The company was founded in 1927 and is headquartered in Yokohama, Japan.
Full JVCZY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.